The effect of quetiapine on alcohol/drug dependents and its abuse: A case series and literature review;Alkol/madde baǧimlilarinda ketiapinin etkisi ve kötüye kullanimi: Olgu serisi ve gözden geçirme

Klinik Psikofarmakoloji Bulteni

Volumn 19, Issue 2, 2009, Pages 148-154

  Evren, Cüneyt ^a,b   Karatepe, Hasan Turan ^a   Aydin, Agah ^a   Dalbudak, Ercan ^a   Cakmak, Duran ^a  

^a AMATEM   (Turkey)

^b NONE   (Turkey)

Author keywords

Abuse; Alcohol dependence; Quetiapine; Substance dependence

Indexed keywords

QUETIAPINE; ZOLPIDEM;

ALCOHOLISM; ARTICLE; COMORBIDITY; DRUG ABUSE; DRUG DEPENDENCE; HUMAN; SUBSTANCE ABUSE;

EID: 67649649630     PISSN: 10177833     EISSN: 13029657     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Reeves RR, Brister JC. Additional Evidence of the Abuse Potential of Quetiapine. South Med J 2007;100:834-836. (Pubitemid 47356887)
2. Adityanjee Schulz SC. Clinical use of quetiapine in disease states other than schizophrenia. J Clin Psychiatry 2002;63 (Suppl 13):32-38. (Pubitemid 35471368)
3. Hussain MZ, Waheed W, Hussain S. Intravenous Quetiapine Abuse. Am J Psychiatry 2005;162:1755-1756.
4. Brown ES, Nejtek VA, Perantie DC, Bobadilla L. Quetiapine in bipolar disorder and cocaine dependence. Bipolar Disord 2002;4:406-411. (Pubitemid 36041471)
5. Cruz HA, Haider S. Effectiveness of quetiapine in patients with dual diagnosis (poster). Presented at the: APAInstitute on Psychiatr Serv, Orlando, FL, 2001.
6. Weisman RL. Quetiapine in the successful treatment of schizophrenia with comorbid alcohol and drug dependence: a case report. Int J Psychiatry Med 2003;33:85-89. (Pubitemid 36927701)
7. Brown ES, Nejtek VA, Perantie DC, Rajan Thomas N, Rush AJ. Cocaine and amphetamine use in patients with psychiatric illness: a randomized trial of typical antipsychotic continuation or discontinuation. J Clin Psychopharmacol 2003;23:384-388. (Pubitemid 36951181)
8. Potvin S, Stip E, Lipp O, Elie R, Mancini-Marië A, Demers MF, Roy MA, Bouchard RH, Gendron A. Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial. Curr Med Res Opin 2006;22:1277-1285. (Pubitemid 44085579)
9. Martinotti G, Andreoli S, Di Nicola M, Sarchiapone M, Janiri L. Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics. Hum Psychopharmacol 2008.
10. Brown ES, Garza M, Carmody TJ. A Randomized, Double-Blind, Placebo-Controlled Add-On Trial of Quetiapine in Outpatients With Bipolar Disorder and Alcohol Use Disorders. J Clin Psychiatry 2008:e1-e5. (Pubitemid 351838678)
11. Pinkofsky HB, Hahn AM, Campbell FA, Rueda J, Daley DC, Douaihy AB. Reduction of opioid-withdrawal symptoms with quetiapine. J Clin Psychiatry 2005;66:1285-1288. (Pubitemid 41546508)
12. Monnelly EP, Ciraulo DA, Knapp C, LoCastro J, Sepulveda I: Quetiapine for treatment of alcohol dependence. J Clin Psychopharmacol 2004;24:532-535. (Pubitemid 39274208)
13. Croissant B, Klein O, Gehrlein L, Kniest A, Hermann D, Diehl A, Mann K. Quetiapine in relapse prevention in alcoholics suffering from craving and affective symptoms: a case series. Eur Psychiatry 2006; 21: 570-573. (Pubitemid 44855529)
14. Mariani JJ, Levin FR. Quetiapine Treatment of Zolpidem Dependence. Am J Addict 2007;16:426. (Pubitemid 47450760)
15. Kampman KM, Pettinati HM, Lynch KG, Whittingham T, Macfadden W, Dackis C, Tirado C, Oslin DW, Sparkman T, O'Brien CP. A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism. J Clin Psychopharmacol 2007;27:344-351. (Pubitemid 47075504)
16. Sattar SP, Bhatia SC, Petty F. Potential benefits of quetiapine in the treatment of substance dependence disorders. J Psychiatry Neurosci 2004;29:452-457. (Pubitemid 40075716)
17. Sattar SP, Schultz SK, Arndt S, Soundy T, Petty F. Long-term adjunctive quetiapine may reduce substance use-a preliminary retrospective study. S D Med 2007;60:437-443.
18. Kennedy A, Wood AE, Saxon AJ, Malte C, Harvey M, Jurik J, Kilzieh N, Lofgreen C, Tapp A. Quetiapine for the treatment of cocaine dependence: an open-label trial. J Clin Psychopharmacol 2008;28:221-224.
19. Pierre JM, Shnayder I, Wirshing DA, Wirshing WC. Intranasal Quetiapine Abuse Am J Psychiatry 2004;161:1718.
20. Morin AK. Possible intranasal quetiapine misuse. Am J Health Syst Pharm 2007;1;64:723-725. (Pubitemid 46515550)
21. Waters BM, Joshi KG. Intravenous Quetiapine-Cocaine Use ("Q-Ball") Am J Psychiatry 2007;164:74.
22. Pinta ER, Taylor RE. Quetiapine Addiction? Am J Psychiatry 2007;164:174-175.
23. Del Paggio D. Psychotropic medication abuse in correctional facilities. The Bay Area Psychopharmacology Newsletter 2005;8:5.
24. Brawman-Mintzer O, Nietert PJ, Rynn MA, ve ark. Quetiapine monotherapy in patients with GAD. Presented at the American Psychiatric Association Annual Meeting, May, 2006, Toronto, Canada, Abstract NR634.
25. Onur E. Panik bozukluǧu tedavisinde ketiapin ile güçlendirme: bir olgu sunumu. Klinik Psikofarmakoloji Bülteni 2007;17:203-206.
26. Kayahan B, Veznedaroǧlu B. Şizofrenide depresif belirtilerin önemi ve psikofarmakolojik saǧaltimi. Klinik Psikofarmakoloji Bülteni 2006;16:52-62.
27. Kose S, Sayar K, Kalelioglu U, Aydin N, Ak I, Kirpinar I, et al. Mizaç ve Karakter Envanteri (Türkçe TCI): geçerlik, güvenirliǧi ve faktör yapisi. Klinik Psikofarmakoloji Bülteni 2004;14:107-131. (Pubitemid 39312614)
28. Villeneuve E, Lemelin S. Open-label study of atypical neuroleptic quetiapine for treatment of borderline personality disorder: impulsivity as main target. J Clin Psychiatry 2005;66:1298-1303. (Pubitemid 41546510)
29. Voruganti L, Cortese L, Oyewumi L, Cernovsky Z, Zirul S, Awad A. Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, sideeffect profile and impact on quality of life. Schizophr Res 2000;43:135-145. (Pubitemid 30386882)
30. Potvin S, Stip E, Roy JY. Clozapine, quetiapine and olanzapine among addicted schizophrenic patients: towards testable hypotheses. Int Clin Psychopharmacol 2003;18:121-132. (Pubitemid 36575481)
31. McBride WJ, Lovinger DM, Machu T, Thielen RJ, Rodd ZA, Murphy JM, Roache JD, Johnson BA. Serotonin-3 receptors in the actions of alcohol, alcohol reinforcement, and alcoholism. Alcohol Clin Exp Res 2004;28:257-267. (Pubitemid 38233603)
32. Potvin S, Kouassi E, Lipp O, Bouchard RH, Roy MA, Demers MF, Gendron A, Astarita G, Piomelli D, Stip E. Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy. J Psychopharmacol 2008. (Pubitemid 351847449)
33. Resnick PJ. The detection of malingered psychosis. Psychiatr Clin North Am 1999;22:159-172. (Pubitemid 29102778)
34. Pierre JM, Wirshing DA, Wirshing WC. "Iatrogenic malingering" in VA substance abuse treatment. Psychiatr Serv 2003;54:253-254.